The Central Bank of Venezuela (Spanish: Banco Central de Venezuela, BCV) is the central bank of Venezuela. It maintains a fixed exchange rate for the Venezuelan bolívar and since 1996 is the governing agent of the Venezuelan Clearing House System (including an automated clearing house).
The organizational climate constitutes one of the elements to be considered in the organizational processes and the quality of public health services. In this article an assessment is made on the subject, with the aim of characterizing the work of our Comprehensive Diagnostic Centers (CDI). Among several arguments, the techniques proposed by Letwin and Stinger are analyzed. Emphasis is placed on the techniques for exploring the organizational climate through four basic dimensions: motivation, leadership, reciprocity, and participation. Document content analysis was carried out, which included original and review articles published from 2001 to 2021, identifying and reviewing articles that were useful for the development of the review, as well as monographs from various journals and updated doctoral theses that allowed the logical historical analysis of the evolution of the definition of organizational climate. The systematization of the terms related to the organizational climate, allowed to define it, with its characteristics, dimensions and importance, however its knowledge is necessary for the improvement of quality in labor institutions.
On December 2019, in Wuhan, China, there was an unusual increase in cases of a fast-progressing acute respiratory infection with high fatality rate. Soon after, the causing agent is identified, a coronavirus called SARS-CoV-2, and a new disease, COVID-19 is characterized. Currently, in the absence of specific, effective and safe treatments, it is justified to explore all scientifically based alternatives available to us, such as the use of Convalescent Plasma (PC-CoV19) as acoadjutant treatment of COVID-19.Plasma from patients who have recovered from an infectious disease, Convalescent Plasma, has been used in the treatment of other infectious disease. There is recent history of its use in diseases caused by another type of coronavirus, and clinical experiences and studies have already been published with preliminary results during this pandemic. Quimbiotec, a Venezuelan State public company that produces blood products and recombinant drugs, and Banco Municipal de Sangre, defined a protocol to promote conditions for aphaeresis, processing, conservation, storage, distribution, transfusion, and evaluation of safety and efficacy of PC-CoV19 as an alternative for the treatment of COVID-19 in Venezuela. This protocol includes identification of capacities, physical structure, equipment and skills, talent, professionals needed, as well as a definition of processes to establish controlled and auditable routines to lay the foundations for access and use of PC-CoV19 in the Venezuela Health System, and prepare the design and implementation of clinical studies. The protocol and currently critical points in its implementation, as well as tools and strategies used for its solution, are presented
